BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33012454)

  • 21. Systematic review of adjuvant external beam radiotherapy for hepatocellular carcinoma following radical hepatectomy.
    Wang L; Qiu L; Ke Q; Ji H; Wu J
    Radiother Oncol; 2022 Oct; 175():101-111. PubMed ID: 35998838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinoma.
    Zeng ZC; Tang ZY; Yang BH; Liu KD; Wu ZQ; Fan J; Qin LX; Sun HC; Zhou J; Jiang GL
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1657-68. PubMed ID: 12458401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [External radiotherapy for hepatocellular carcinoma].
    Girard N; Mornex F
    Cancer Radiother; 2011 Feb; 15(1):49-53. PubMed ID: 21237691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspectives on radiotherapy in hepatocellular carcinoma management: a comprehensive review.
    Kim D; Kim JS
    J Liver Cancer; 2024 Mar; 24(1):33-46. PubMed ID: 38523467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-arterial chemoembolization and external beam radiation therapy for treatment of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium.
    Duan F; Yu W; Wang Y; Liu FY; Song P; Wang ZJ; Yan JY; Yuan K; Wang MQ
    Cancer Imaging; 2015 May; 15(1):7. PubMed ID: 26007646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients.
    Zeng ZC; Tang ZY; Fan J; Qin LX; Ye SL; Zhou J; Sun HC; Wang BL; Wang JH
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1067-76. PubMed ID: 15913915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of radiotherapy and chemoradiation in the management of primary liver tumours.
    Aitken KL; Hawkins MA
    Clin Oncol (R Coll Radiol); 2014 Sep; 26(9):569-80. PubMed ID: 24951335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in external beam stereotactic body radiotherapy: principle concerns in implementing a liver radiation program.
    Gaede S; Lock MI
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S13. PubMed ID: 28917251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation therapy for hepatocellular carcinoma: from palliation to cure.
    Hawkins MA; Dawson LA
    Cancer; 2006 Apr; 106(8):1653-63. PubMed ID: 16541431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy has been shown to be adaptable for various stages of hepatocellular carcinoma.
    Kondo Y; Kimura O; Shimosegawa T
    World J Gastroenterol; 2015 Jan; 21(1):94-101. PubMed ID: 25574082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External Beam Radiation Therapy for Liver Metastases.
    Romesser PB; Neal BP; Crane CH
    Surg Oncol Clin N Am; 2021 Jan; 30(1):159-173. PubMed ID: 33220803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volumetric intensity-modulated Arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy.
    Kuo YC; Chiu YM; Shih WP; Yu HW; Chen CW; Wong PF; Lin WC; Hwang JJ
    Radiat Oncol; 2011 Jun; 6():76. PubMed ID: 21693003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Powerful radiotherapy for hepatocellular carcinoma.
    Matsuzaki Y
    J Gastroenterol Hepatol; 1999 Oct; 14(10):941-5. PubMed ID: 10530488
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinoma.
    Park S; Yoon WS; Jang MH; Rim CH
    Int J Radiat Biol; 2020 Dec; 96(12):1541-1549. PubMed ID: 32990486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; He J; Zeng HY; Chang JY
    Mol Biol Rep; 2012 Feb; 39(2):2021-9. PubMed ID: 21647551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry.
    Wang TH; Huang PI; Hu YW; Lin KH; Liu CS; Lin YY; Liu CA; Tseng HS; Liu YM; Lee RC
    PLoS One; 2018; 13(1):e0190098. PubMed ID: 29293557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Soni PD; Palta M
    Dig Dis Sci; 2019 Apr; 64(4):1008-1015. PubMed ID: 30868409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
    Choi SH; Seong J
    Yonsei Med J; 2018 Oct; 59(8):912-922. PubMed ID: 30187697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indications of external radiotherapy for hepatocellular carcinoma from updated clinical guidelines: Diverse global viewpoints.
    Park S; Yoon WS; Rim CH
    World J Gastroenterol; 2020 Jan; 26(4):393-403. PubMed ID: 32063688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Charged-particle therapy for hepatocellular carcinoma.
    Skinner HD; Hong TS; Krishnan S
    Semin Radiat Oncol; 2011 Oct; 21(4):278-86. PubMed ID: 21939857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.